These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21070503)

  • 1. Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.
    Sockalingam S; Links PS; Abbey SE
    J Viral Hepat; 2011 Mar; 18(3):153-60. PubMed ID: 21070503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.
    Quelhas R; Lopes A
    J Psychiatr Pract; 2009 Jul; 15(4):262-81. PubMed ID: 19625882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of sleep disturbance in hepatitis C.
    Sockalingam S; Abbey SE; Alosaimi F; Novak M
    J Clin Gastroenterol; 2010 Jan; 44(1):38-45. PubMed ID: 19730115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
    Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence, course and risk factors of depression during antiviral treatment for chronic hepatitis C in patients with inherited bleeding disorders: a prospective study.
    Fransen Van De Putte DE; Fischer K; Posthouwer D; Van Erpecum K; Mauser-Bunschoten EP
    Haemophilia; 2009 Mar; 15(2):544-51. PubMed ID: 19175422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Lin ZY; Hou NJ; Hsieh MY; Wang LY; Yu ML
    Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
    Smith JP
    Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha].
    Rifflet H; Vuillemin E; Oberti F; Duverger P; Lainé P; Garré JB; Calés P
    Gastroenterol Clin Biol; 1998 Mar; 22(3):353-7. PubMed ID: 9762223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
    Raison CL; Woolwine BJ; Demetrashvili MF; Borisov AS; Weinreib R; Staab JP; Zajecka JM; Bruno CJ; Henderson MA; Reinus JF; Evans DL; Asnis GM; Miller AH
    Aliment Pharmacol Ther; 2007 May; 25(10):1163-74. PubMed ID: 17451562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal ideation with IFN-alpha and ribavirin in a patient with hepatitis C.
    Ademmer K; Beutel M; Bretzel R; Jaeger C; Reimer C
    Psychosomatics; 2001; 42(4):365-7. PubMed ID: 11496031
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment.
    Lucaciu LA; Dumitrascu DL
    Ann Gastroenterol; 2015; 28(4):440-7. PubMed ID: 26424594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.